COVID-19 in Solid Organ Transplantation: Results of the National COVID Cohort Collaborative

Amanda J Vinson, Gaurav Agarwal, Ran Dai, Alfred J Anzalone, Stephen B Lee, Evan French, Amy Olex, Vithal Madhira, Roslyn B Mannon

Research output: Contribution to journalArticlepeer-review


Coronavirus disease 2019 (COVID-19) has resulted in significant morbidity and mortality in solid organ transplant (SOT) recipients. The National COVID Cohort Collaborative was developed to facilitate analysis of patient-level data for those tested for COVID-19 across the United States.

Methods: In this study, we identified a cohort of SOT recipients testing positive or negative for COVID-19 (COVID+ and COVID-, respectively) between January 1, 2020, and November 20, 2020. Univariable and multivariable logistic regression were used to determine predictors of a positive result among those tested. Outcomes following COVID-19 diagnosis were also explored.

Results: Of 18 121 SOT patients tested, 1925 were positive (10.6%). COVID+ SOT patients were more likely to have a kidney transplant and be non-White race. Comorbidities were common in all SOT patients but significantly more common in those who were COVID+. Of COVID+ SOT, 42.9% required hospital admission. COVID+ status was the strongest predictor of acute kidney injury (AKI), rejection, and graft failure in the 90 d after testing. A total of 40.9% of COVID+ SOT experienced a major adverse renal or cardiac event, 16.3% experienced a major adverse cardiac event, 35.3% experienced AKI, and 1.5% experienced graft loss.

Conclusions: In the largest US cohort of COVID+ SOT recipients to date, we identified patient factors associated with the diagnosis of COVID-19 and outcomes following infection, including a high incidence of major adverse renal or cardiac event and AKI.

Original languageEnglish (US)
Pages (from-to)e775
JournalTransplantation Direct
Issue number11
StatePublished - Nov 2021


Dive into the research topics of 'COVID-19 in Solid Organ Transplantation: Results of the National COVID Cohort Collaborative'. Together they form a unique fingerprint.

Cite this